Laddar...
AML chemoresistance: The role of mutant TP53 subclonal expansion and therapy strategy
Acute myeloid leukemia (AML) is a heterogeneous clonal disease characterized by the proliferation and accumulation of myeloid blast cells in the bone marrow which eventually leads to hematopoietic failure. Chemoresistance presents as a major burden for therapy of AML patients. TP53 is the most impor...
Sparad:
| I publikationen: | Exp Hematol |
|---|---|
| Huvudupphovsmän: | , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
2020
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7416446/ https://ncbi.nlm.nih.gov/pubmed/32569759 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.exphem.2020.06.003 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|